Description of the blood test:

The Cytomegalovirus (CMV) IgG Avidity test is a specialized secondary analysis used to determine the “age” of a CMV infection. While standard tests tell you if antibodies are present, they often cannot distinguish between an infection that happened two weeks ago and one that happened two years ago. The avidity test measures the strength of the bond between IgG antibodies and the virus. This strength (avidity) increases over time as the immune system matures its response, making this test the gold standard for dating an infection, which is vital for managing health risks during pregnancy.

What does the analysis represent?

• Maturity Marker: It measures how tightly the IgG antibodies bind to the CMV virus.
• Low Avidity: Indicates “weak” bonds, typically seen in the first 3 to 4 months after a primary infection.
• High Avidity: Indicates “strong” bonds, confirming that the infection occurred at least 3 to 6 months in the past.
• Performance: A complex biochemical assay (ELISA) performed on a venous blood sample, comparing the binding strength in the presence of a protein-denaturing agent.

Recommendations for the test (General)

• Pre-requisite: This test is only performed if CMV IgG antibodies have already been detected in the blood.
• Time: Morning hours are preferred for blood collection.
• Fasting: An 8-hour food intake pause is recommended.
• Stability: Avoid intense physical exertion the day before to ensure stable laboratory parameters.
• Important: This test is most effective when performed as soon as a positive IgM or IgG result is discovered, especially in the first trimester of pregnancy.

What can affect the results?

• Individual Variation: Some individuals naturally take longer for their antibody avidity to mature, which might result in a persistent low avidity that lasts longer than 4 months.
• Reactivation: In some cases of viral reactivation, the avidity remains high, helping to rule out a dangerous primary infection.
• Immune Treatments: Recent administration of immunoglobulin therapy can interfere with the measurement of the patient’s own antibody strength.

When to take the test?

• Recommendations: Primarily prescribed when both CMV IgM and IgG are positive (especially in pregnant women) to determine if the infection was contracted during the pregnancy or before conception.
• Preparation: No special physical preparation is needed beyond standard fasting; however, clinical history (dates of previous tests) is very helpful for the specialist.

How to interpret the results?

The interpretation of data is the exclusive responsibility of an infectious disease specialist or an obstetrician-gynecologist. An “Avidity Index” is calculated: a low index suggests a recent (primary) infection, while a high index provides reassurance that the infection is old and the patient has stable immunity. Only an expert can use this index to assess the risk of transmission to a fetus or to determine if antiviral therapy is warranted. This is not a diagnostic tool for general illness, but a precise chronological tool.

Possible further investigations

• CMV DNA PCR (Quantitative): To check for the presence of the actual virus in the blood if avidity is low.
• Ultrasound Monitoring: Specialized scans if a recent infection is confirmed during pregnancy.
• Amniocentesis: In specific clinical cases, to check for the virus in the amniotic fluid.
• Consultation with an Infectious Disease Specialist: To evaluate the chronological data and plan management.

When does the next step make sense?

The timing of a CMV infection is the most critical factor in risk assessment. Once the avidity result is obtained, the next step is an immediate consultation with a specialist to discuss the timeline of the infection and ensure the safety of both the patient and, in the case of pregnancy, the developing child.

👉 If necessary, you can discuss the test results with our specialized — dermatology disease specialist (Doctors – TAMC).